Shanghai, China

Xiaodan Yan

This inventor holds 1 USPTO granted patent. Top assignees: Jiangsu Hengrui Medicine Company Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaodan Yan. Retrieved from https://idiyas.com/inventor/xiaodan-yan-fxufdywr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xiaodan Yan - Innovator in Pharmaceutical Composition

Introduction

Xiaodan Yan is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibody compositions. His work has the potential to impact therapeutic approaches in various medical conditions.

Latest Patents

Xiaodan Yan holds a patent for a PD-L1 antibody pharmaceutical composition and its use. The invention provides a pharmaceutical composition that includes the PD-L1 antibody or an antigen-binding fragment in a succinate buffer. Additionally, the composition may contain a sugar and a nonionic surfactant, enhancing its efficacy and stability.

Career Highlights

Throughout his career, Xiaodan Yan has worked with prominent companies in the pharmaceutical industry. He has been associated with Shanghai Hengrui Pharmaceutical Co., Ltd. and Jiangsu Hengrui Medicine Company Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Xiaodan Yan has collaborated with notable colleagues, including Zhen Yan and Shan Wu. These partnerships have likely fostered a productive environment for research and development in their respective fields.

Conclusion

Xiaodan Yan is a distinguished inventor whose work in PD-L1 antibody pharmaceutical compositions showcases his innovative spirit. His contributions to the pharmaceutical industry are noteworthy and reflect his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…